Jeffrey Del Carmen Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Jeffrey Del Carmen is Chief Commercial Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,369 shares of CPRX, which is worth approximately $253,564. The most recent transaction as insider was on Aug 09, 2024, when has been sold 36,058 shares (Common Stock, par value $0.001 per share) at a price of $18.43 per share, resulting in proceeds of $664,548. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4K

32.88% 3M change

9.04% 12M change

Total Value Held $253,564

Jeffrey Del Carmen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 09 2024	SELL Open market or private sale	$664,548 $18.43 p/Share	36,058 Reduced 74.46%	12,369 Common Stock, par valu...
Aug 09 2024	BUY Exercise of conversion of derivative security	$85,800 $2.86 p/Share	30,000 Added 41.45%	42,369 Common Stock, par valu...
Jun 07 2024	SELL Open market or private sale	$121,183 $16.07 p/Share	7,541 Reduced 29.04%	18,427 Common Stock, par valu...
Feb 15 2024	SELL Payment of exercise price or tax liability	-	3,125 Reduced 10.74%	25,968 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	10,667 Added 26.83%	29,093 Common Stock, par valu...
Dec 27 2023	SELL Payment of exercise price or tax liability	-	3,839 Reduced 17.24%	18,426 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	8,666 Added 28.02%	22,265 Common Stock, par valu...
Jun 27 2023	SELL Payment of exercise price or tax liability	-	3,942 Reduced 22.47%	13,599 Common Stock, par valu...
Jun 27 2023	BUY Exercise of conversion of derivative security	-	10,000 Added 36.31%	17,541 Common Stock, par valu...
Mar 29 2023	SELL Open market or private sale	$668,000 $16.7 p/Share	40,000 Reduced 84.14%	7,541 Common Stock, par valu...
Mar 29 2023	BUY Exercise of conversion of derivative security	$129,200 $3.23 p/Share	40,000 Added 60.1%	26,558 Common Stock, par valu...
Feb 15 2023	SELL Payment of exercise price or tax liability	-	3,125 Reduced 29.3%	7,541 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	10,666 Added 50.0%	10,666 Common Stock, par valu...
Nov 11 2022	SELL Open market or private sale	$2,203,419 $15.85 p/Share	139,017 Reduced 100.0%	0 Common Stock, par valu...
Nov 11 2022	BUY Exercise of conversion of derivative security	$354,493 $2.55 p/Share	139,017 Added 87.97%	19,017 Common Stock, par valu...
Aug 19 2022	BUY Open market or private sale	$198,667 $14.05 p/Share	14,140 Added 100.0%	0 Common Stock, par valu...
Jun 28 2022	SELL Payment of exercise price or tax liability	-	2,930 Reduced 17.16%	14,140 Common Stock, par valu...
Jun 28 2022	BUY Exercise of conversion of derivative security	-	10,000 Added 36.94%	17,070 Common Stock, par valu...
Jun 24 2021	SELL Payment of exercise price or tax liability	-	2,930 Reduced 29.3%	7,070 Common Stock, par valu...
Jun 24 2021	BUY Exercise of conversion of derivative security	-	10,000 Added 50.0%	10,000 Common Stock, par valu...

JDC

Jeffrey Del Carmen

Chief Commercial Officer

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account